BILL W. COLSTON, PH.D.

Corporate Board Profile

Tech Score: 100/100

Software Technology Evidence

1 mention(s) identify BILL W. COLSTON, PH.D. as having software/technology expertise.

Company	Filing Date	Evidence	Reason
STANDARD BIOTOOLS INC.	2021-04-14	Dr. Colston received his B.A. in biology/biological sciences from the University of Texas at Austin in May 1989, and his Ph.D. in biomedical engineering from the University of California, Davis, in December 1997. He founded a privately held company in the synthetic biology space, Sestina Bio, LLC, and served as CEO of HealthTell Inc., a company focused on developing next generation tests that broadly characterize the immune system.	Has a Ph.D. in biomedical engineering and founded a synthetic biology company; extensive scientific background including leadership roles in biotechnology and genetic analysis system development.

STANDARD BIOTOOLS INC.

Filing Date	Source Excerpt
2021-04-14	Dr. Colston received his B.A. in biology/biological sciences from the University of Texas at Austin in May 1989, and his Ph.D. in biomedical engineering from the University of California, Davis, in December 1997. He founded a privately held company in the synthetic biology space, Sestina Bio, LLC, and served as CEO of HealthTell Inc., a company focused on developing next generation tests that broadly characterize the immune system.

Filing Date

Source Excerpt

2021-04-14

Dr. Colston received his B.A. in biology/biological sciences from the University of Texas at Austin in May 1989, and his Ph.D. in biomedical engineering from the University of California, Davis, in December 1997. He founded a privately held company in the synthetic biology space, Sestina Bio, LLC, and served as CEO of HealthTell Inc., a company focused on developing next generation tests that broadly characterize the immune system.

Data sourced from SEC filings. Last updated: 2026-02-03